ArticleInternational journal of molecular sciences2025

Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report.

Daniel Munarriz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.